Andrew Grulich

HIV diagnoses in Australia remained low in 2022: new data

20 Jul 2023

Despite disruptions to testing and risk behaviour during COVID-19, the latest data from UNSW Sydney’s Kirby Institute shows Australia is tracking well towards the elimination of HIV transmission.

Lord Glendonbrook (third from left) with colleagues and Kirby Institute researchers outside the Glendonbrook laboratories

$5M philanthropic gift to the Kirby Institute from The Glendonbrook Foundation

10 Mar 2023

The major gift will support prevention research for one of Australia’s most neglected cancers.

STIs are down, but fewer tests could be the cause

08 Dec 2022

A new report finds most STIs in Australia remain undiagnosed and untreated, highlighting a need to increase STI testing across the country.

Research collaboration to provide data needed to stop monkeypox in its TraX

06 Oct 2022

The Kirby Institute is calling for people at risk of monkeypox to enrol in the TraX study to help shape the public health response.

Australia records lowest ever HIV numbers, but late diagnoses are concerning

30 Aug 2022

The sustained downward trend is likely due to high uptake of prevention measures, testing and high levels of treatment.

UNSW tops nation in NHMRC Partnership grants

15 Sep 2021

UNSW Sydney researchers have secured more than $6 million for five projects that will improve public health services.

Continuing declines in HIV diagnoses thanks to successful PrEP roll-out in NSW

02 Jul 2021

Researchers have revealed the final results of the first study that measured the impact of PrEP on reducing HIV in a large population.

HIV in Australia has declined by 12 per cent in the past five years

01 Dec 2020

New HIV data, released today by the Kirby Institute at UNSW Sydney for World AIDS Day, are a reminder for Australia to sustain its efforts in HIV prevention amidst the COVID-19 pandemic.

PrEP trial leads to unprecedented reductions in HIV transmission

18 Oct 2018

A global-first, UNSW-led trial of an HIV prevention medication has resulted in an almost one-third decline in infections in the large-scale target group.

EPIC trial enrols 1000th participant as access to PrEP expands

20 May 2016

NSW is on track to virtually eliminate HIV transmission by 2020 as an expanded PrEP trial, led by the Kirby Institute at UNSW, enrols its one thousandth participant in record time.

Andrew Grulich

Pages